JAKAVI

Tablet, 15mg
RxActive license

Active substance (INN)

ruxolitinib

Pharmaceutical form

Pharmaceutical formTablet
Strength15mg
PackagingUkupno 56 tableta u blisteru (4x14) u kartonskoj kutiji
ManufacturerNovartis Pharma Stein AG, Switzerland
Therapeutic groupAntineoplastic and immunomodulating agents (L01EJ01)
Marketing authorization holder"NOVARTIS PHARMA SERVICES AG" DIO STRANOG DRUŠTVA PODGORICA
Authorization dateJanuary 14, 2025

Analogs in Montenegro

2

Other medicines with the same active substance

JAKAVIRx
Tablet, 5mgNovartis Pharma Stein AG
JAKAVIRx
Tablet, 20mgNovartis Pharma Stein AG
Source: CInMED register